- Investing Ideas
- Danish Healthy potentially undervalued
Danish Healthy potentially undervalued
Results
9
Companies which are potentially undervalued and in an acceptable financial position.
9 companies
Bavarian Nordic
Market Cap: DKK 14.9b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 192.55
7D
-2.6%
1Y
10.9%
Demant
Market Cap: DKK 38.7b
Operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally.
DEMANT
DKK 183.40
7D
-17.5%
1Y
-31.5%
Coloplast
Market Cap: DKK 108.3b
Engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.
COLO B
DKK 481.00
7D
-10.4%
1Y
-38.6%
H. Lundbeck
Market Cap: DKK 37.5b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 38.50
7D
-9.6%
1Y
-10.2%
Genmab
Market Cap: DKK 119.0b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,931.50
7D
-7.6%
1Y
41.2%
Jyske Bank
Market Cap: DKK 56.9b
Provides financial solutions in Denmark and Germany.
JYSK
DKK 978.50
7D
4.2%
1Y
83.8%
Novo Nordisk
Market Cap: DKK 1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 311.00
7D
-16.6%
1Y
-49.5%
Embla Medical hf
Market Cap: DKK 13.3b
Provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
EMBLA
DKK 31.10
7D
-1.9%
1Y
-9.6%
Vestas Wind Systems
Market Cap: DKK 163.0b
Engages in the design, manufacture, installation, and services of wind turbines the United States, Denmark, and internationally.
VWS
DKK 164.60
7D
-16.6%
1Y
59.7%